A citation-based method for searching scientific literature

Thomas A Ciulla, Peter Bracha, John Pollack, David F Williams. Ophthalmol Retina 2018
Times Cited: 61







List of co-cited articles
296 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Quan Dong Nguyen, David M Brown, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Andrea Gibson, Judy Sy, Amy Chen Rundle, J Jill Hopkins,[...]. Ophthalmology 2012
45

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema: Two-Year Results from a Comparative Effectiveness Randomized Clinical Trial.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Neil M Bressler, Susan B Bressler, Alexander J Brucker, Frederick L Ferris, G Robert Hampton, Chirag Jhaveri,[...]. Ophthalmology 2016
472
36

Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema.
John A Wells, Adam R Glassman, Allison R Ayala, Lee M Jampol, Lloyd Paul Aiello, Andrew N Antoszyk, Bambi Arnold-Bush, Carl W Baker, Neil M Bressler, David J Browning,[...]. N Engl J Med 2015
883
34

Intravitreal aflibercept for diabetic macular edema.
Jean-François Korobelnik, Diana V Do, Ursula Schmidt-Erfurth, David S Boyer, Frank G Holz, Jeffrey S Heier, Edoardo Midena, Peter K Kaiser, Hiroko Terasaki, Dennis M Marcus,[...]. Ophthalmology 2014
465
31

Vision Outcomes Following Anti-Vascular Endothelial Growth Factor Treatment of Diabetic Macular Edema in Clinical Practice.
Nancy M Holekamp, Joanna Campbell, Arghavan Almony, Herbert Ingraham, Steven Marks, Hitesh Chandwani, Ashley L Cole, Szilárd Kiss. Am J Ophthalmol 2018
48
35

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
Paul Mitchell, Francesco Bandello, Ursula Schmidt-Erfurth, Gabriele E Lang, Pascale Massin, Reinier O Schlingemann, Florian Sutter, Christian Simader, Gabriela Burian, Ortrud Gerstner,[...]. Ophthalmology 2011
883
22

Global prevalence and major risk factors of diabetic retinopathy.
Joanne W Y Yau, Sophie L Rogers, Ryo Kawasaki, Ecosse L Lamoureux, Jonathan W Kowalski, Toke Bek, Shih-Jen Chen, Jacqueline M Dekker, Astrid Fletcher, Jakob Grauslund,[...]. Diabetes Care 2012
22

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
Michael J Elman, Lloyd Paul Aiello, Roy W Beck, Neil M Bressler, Susan B Bressler, Allison R Edwards, Frederick L Ferris, Scott M Friedman, Adam R Glassman, Kellee M Miller,[...]. Ophthalmology 2010
926
22

Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
David M Brown, Quan Dong Nguyen, Dennis M Marcus, David S Boyer, Sunil Patel, Leonard Feiner, Patricio G Schlottmann, Amy Chen Rundle, Jiameng Zhang, Roman G Rubio,[...]. Ophthalmology 2013
540
21

Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Jeffrey S Heier, Jean-François Korobelnik, David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Edoardo Midena, David S Boyer, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2016
192
21

Guidelines for the Management of Diabetic Macular Edema by the European Society of Retina Specialists (EURETINA).
Ursula Schmidt-Erfurth, Jose Garcia-Arumi, Francesco Bandello, Karina Berg, Usha Chakravarthy, Bianca S Gerendas, Jost Jonas, Michael Larsen, Ramin Tadayoni, Anat Loewenstein. Ophthalmologica 2017
245
18

Anti-VEGF treatment of diabetic macular edema in clinical practice: effectiveness and patterns of use (ECHO Study Report 1).
Kevin J Blinder, Pravin U Dugel, Sanford Chen, J Michael Jumper, John G Walt, David A Hollander, Lanita C Scott. Clin Ophthalmol 2017
69
16

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.
David S Boyer, Young Hee Yoon, Rubens Belfort, Francesco Bandello, Raj K Maturi, Albert J Augustin, Xiao-Yan Li, Harry Cui, Yehia Hashad, Scott M Whitcup. Ophthalmology 2014
609
16

Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema.
Peter A Campochiaro, David M Brown, Andrew Pearson, Sanford Chen, David Boyer, Jose Ruiz-Moreno, Bruce Garretson, Amod Gupta, Seenu M Hariprasad, Clare Bailey,[...]. Ophthalmology 2012
304
16


Clinical utilization of anti-vascular endothelial growth-factor agents and patient monitoring in retinal vein occlusion and diabetic macular edema.
Szilárd Kiss, Ying Liu, Joseph Brown, Nancy M Holekamp, Arghavan Almony, Joanna Campbell, Jonathan W Kowalski. Clin Ophthalmol 2014
70
14

Novel method for analyzing snellen visual acuity measurements.
Ninel Z Gregori, William Feuer, Philip J Rosenfeld. Retina 2010
312
14


Ranibizumab for neovascular age-related macular degeneration.
Philip J Rosenfeld, David M Brown, Jeffrey S Heier, David S Boyer, Peter K Kaiser, Carol Y Chung, Robert Y Kim. N Engl J Med 2006
14

Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
David M Brown, Ursula Schmidt-Erfurth, Diana V Do, Frank G Holz, David S Boyer, Edoardo Midena, Jeffrey S Heier, Hiroko Terasaki, Peter K Kaiser, Dennis M Marcus,[...]. Ophthalmology 2015
303
13

Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.
Ryan Lee, Tien Y Wong, Charumathi Sabanayagam. Eye Vis (Lond) 2015
578
13


Persistent Macular Thickening Following Intravitreous Aflibercept, Bevacizumab, or Ranibizumab for Central-Involved Diabetic Macular Edema With Vision Impairment: A Secondary Analysis of a Randomized Clinical Trial.
Neil M Bressler, Wesley T Beaulieu, Adam R Glassman, Kevin J Blinder, Susan B Bressler, Lee M Jampol, Michele Melia, John A Wells. JAMA Ophthalmol 2018
121
13

The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.
Catherine Egan, Haogang Zhu, Aaron Lee, Dawn Sim, Danny Mitry, Clare Bailey, Robert Johnston, Usha Chakravarthy, Alastair Denniston, Adnan Tufail,[...]. Br J Ophthalmol 2017
43
16

Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV.
Thomas Wecker, Christoph Ehlken, Anima Bühler, Clemens Lange, Hansjürgen Agostini, Daniel Böhringer, Andreas Stahl. Br J Ophthalmol 2017
81
11

Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.
Arup Das, Paul G McGuire, Sampathkumar Rangasamy. Ophthalmology 2015
257
11

COMPLIANCE AND ADHERENCE OF PATIENTS WITH DIABETIC MACULAR EDEMA TO INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN DAILY PRACTICE.
Maximilian Weiss, Dawn A Sim, Tina Herold, Ricarda G Schumann, Raffael Liegl, Christoph Kern, Thomas Kreutzer, Johannes Schiefelbein, Miriam Rottmann, Siegfried Priglinger,[...]. Retina 2018
62
11

Ranibizumab and bevacizumab for neovascular age-related macular degeneration.
Daniel F Martin, Maureen G Maguire, Gui-shuang Ying, Juan E Grunwald, Stuart L Fine, Glenn J Jaffe. N Engl J Med 2011
11

Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory.
Pedro Romero-Aroca, Marc Baget-Bernaldiz, Alicia Pareja-Rios, Maribel Lopez-Galvez, Raul Navarro-Gil, Raquel Verges. J Diabetes Res 2016
141
9

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials.
Pravin U Dugel, Jost Hillenkamp, Sobha Sivaprasad, Jessica Vögeler, Marie-Catherine Mousseau, Andreas Wenzel, Philippe Margaron, Ron Hashmonay, Pascale Massin. Clin Ophthalmol 2016
43
13

Diabetic Macular Edema Diagnosis and Treatment in the Real World: An Analysis of Medicare Claims Data (2008 to 2010).
Pravin U Dugel, Andrew Layton, Rohit B Varma. Ophthalmic Surg Lasers Imaging Retina 2016
28
21

Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M Brown, Mark Michels, Peter K Kaiser, Jeffrey S Heier, Judy P Sy, Tsontcho Ianchulev. Ophthalmology 2009
950
9

Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting.
Namritha V Patrao, Sheelah Antao, Catherine Egan, Amer Omar, Robin Hamilton, Philip G Hykin, Sobha Sivaprasad, Ranjan Rajendram. Am J Ophthalmol 2016
54
11

Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M Brown, Peter K Kaiser, Mark Michels, Gisele Soubrane, Jeffrey S Heier, Robert Y Kim, Judy P Sy, Susan Schneider. N Engl J Med 2006
9

Trends in the Care of Diabetic Macular Edema: Analysis of a National Cohort.
Brian L VanderBeek, Neepa Shah, Purak C Parikh, Liyuan Ma. PLoS One 2016
21
28

Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema.
David J Browning, Adam R Glassman, Lloyd Paul Aiello, Roy W Beck, David M Brown, Donald S Fong, Neil M Bressler, Ronald P Danis, James L Kinyoun, Quan Dong Nguyen,[...]. Ophthalmology 2007
391
9

The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema.
Alexander Eaton, Sean S Koh, Jaime Jimenez, Christopher D Riemann. Ophthalmol Ther 2019
31
19

Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients.
Christoph Ehlken, Mandy Helms, Daniel Böhringer, Hansjürgen T Agostini, Andreas Stahl. Clin Ophthalmol 2017
68
9

Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration.
Jeffrey S Heier, David M Brown, Victor Chong, Jean-Francois Korobelnik, Peter K Kaiser, Quan Dong Nguyen, Bernd Kirchhof, Allen Ho, Yuichiro Ogura, George D Yancopoulos,[...]. Ophthalmology 2012
9

Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: 52-Week Results of the VIBRANT Study.
W Lloyd Clark, David S Boyer, Jeffrey S Heier, David M Brown, Julia A Haller, Robert Vitti, Husain Kazmi, Alyson J Berliner, Kristine Erickson, Karen W Chu,[...]. Ophthalmology 2016
137
9

Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO Study.
Jean-François Korobelnik, Frank G Holz, Johann Roider, Yuichiro Ogura, Christian Simader, Ursula Schmidt-Erfurth, Katrin Lorenz, Miki Honda, Robert Vitti, Alyson J Berliner,[...]. Ophthalmology 2014
177
9

Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.
Sanjeeb Bhandari, Vuong Nguyen, Samantha Fraser-Bell, Hemal Mehta, Francesco Viola, Florian Baudin, Pierre-Henry Gabrielle, Catherine Creuzot-Garcher, Mark Gillies, Daniel Barthelmes. Ophthalmology 2020
24
25

Real-world outcomes following 12 months of intravitreal aflibercept monotherapy in patients with diabetic macular edema in France: results from the APOLLON study.
Jean-François Korobelnik, Vincent Daien, Céline Faure, Ramin Tadayoni, Audrey Giocanti-Auregan, Corinne Dot, Laurent Kodjikian, Pascale Massin. Graefes Arch Clin Exp Ophthalmol 2020
16
37

Safety and efficacy of ranibizumab in diabetic macular edema (RESOLVE Study): a 12-month, randomized, controlled, double-masked, multicenter phase II study.
Pascale Massin, Francesco Bandello, Justus G Garweg, Lutz L Hansen, Simon P Harding, Michael Larsen, Paul Mitchell, Dianne Sharp, U E K Wolf-Schnurrbusch, Margarita Gekkieva,[...]. Diabetes Care 2010
478
8

Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
Thomas A Ciulla, Armando G Amador, Bernard Zinman. Diabetes Care 2003
434
8

Two-year safety and efficacy of ranibizumab 0.5 mg in diabetic macular edema: interim analysis of the RESTORE extension study.
Gabriele E Lang, András Berta, Bora M Eldem, Christian Simader, Dianne Sharp, Frank G Holz, Florian Sutter, Ortrud Gerstner, Paul Mitchell. Ophthalmology 2013
88
8

A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
Ranjan Rajendram, Samantha Fraser-Bell, Andrew Kaines, Michel Michaelides, Robin D Hamilton, Simona Degli Esposti, Tunde Peto, Catherine Egan, Catey Bunce, Richard David Leslie,[...]. Arch Ophthalmol 2012
253
8


The REVEAL Study: Ranibizumab Monotherapy or Combined with Laser versus Laser Monotherapy in Asian Patients with Diabetic Macular Edema.
Tatsuro Ishibashi, Xiaoxin Li, Adrian Koh, Timothy Y Y Lai, Fenq-Lih Lee, Won-Ki Lee, Zhizhong Ma, Masahito Ohji, Nikolle Tan, Sung Bok Cha,[...]. Ophthalmology 2015
99
8

Factors associated with changes in visual acuity and central subfield thickness at 1 year after treatment for diabetic macular edema with ranibizumab.
Susan B Bressler, Haijing Qin, Roy W Beck, Kakarla V Chalam, Judy E Kim, Michele Melia, John A Wells. Arch Ophthalmol 2012
182
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.